Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]
0 reported adverse events
These side effects are most commonly reported by patients taking drugs of the Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC] class:
Drugs of the Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC] class are most commonly taken among patients reporting these side effects: